Marex Discloses $9.4M XRP ETF Bet as Institutional Interest Grows

Marex Group just put fresh fuel on the XRP ETF fire, disclosing a $9.4 million position across two spot XRP funds in its latest SEC filing. The move makes the Nasdaq-listed financial services firm one of the more notable institutional holders of XRP ETF shares in the U.S. — and, naturally, the crypto market has started sniffing around for a bigger story.

• $9.4 million combined position in spot XRP ETFs
• 51% quarter-over-quarter increase in Canary XRP ETF holdings
• More Bitcoin-linked exposure via Strategy, with some other digital asset bets trimmed
• Bullish for XRP ETF adoption, but not proof of long-term conviction

The disclosure came through a 13F filing with the U.S. Securities and Exchange Commission (SEC). For anyone not living and breathing Wall Street paperwork, a 13F is a quarterly report big investment managers must file to show certain holdings. It’s basically the market’s little window into what the suits were buying, selling, and pretending they “saw coming.”

In Marex’s case, the filing showed two spot XRP ETF positions. The firm held 356,865 shares of the Canary XRP ETF, worth about $5.1 million, and added 286,021 new shares of the Bitwise XRP ETF, worth nearly $4.3 million. Combined, that brought the total to $9.4 million, with the Canary stake climbing 51% quarter-over-quarter.

That’s a meaningful number, especially because spot XRP ETFs give institutions exposure to XRP’s price without forcing them to custody the token directly. In plain English: they can buy a familiar listed product instead of dealing with wallets, private keys, and the compliance headaches that make traditional finance break out in hives.

Marex’s buying pushed the firm into the ranks of the larger institutional XRP ETF holders in the U.S. It still trails the heavyweights by a wide margin. Goldman Sachs reported $152.16 million in XRP ETF exposure, while Millennium Management held more than $27 million. Marex is not leading the pack, but the size and speed of its quarterly increase stand out.

The market noticed. Marex Group’s stock rose more than 15% in a week after the disclosure, and shares closed up 4.20% at $58.25 on Wednesday. The stock is now up more than 50% year-to-date. Wall Street loves a whiff of crypto exposure, even when the actual data is a lot more measured than the hopium brigade would like.

Marex did not stop at XRP. The filing also showed a bigger appetite for Strategy, the Bitcoin-heavy public company formerly known as MicroStrategy. Its holdings in MSTR increased from 2.9 million shares to 3.4 million, while Strategy call options were cut from 108,100 to 65,500. That matters because call options are contracts that give the right to buy shares at a set price; trimming them while adding stock suggests a shift toward more direct exposure and less leveraged speculation.

The firm also expanded its position in STRK, Strategy’s perpetual preferred shares, from 4,400 to 16,401. Preferred shares sit between common stock and debt in the capital stack, often offering different income and risk characteristics. In other words, Marex wasn’t just betting on one clean crypto narrative — it was spreading exposure across several public-market vehicles tied to digital assets.

At the same time, Marex trimmed exposure to TON Strategy and Bitmine Immersion Technologies. That suggests the firm is not blindly hoovering up every crypto-linked ticker with a pulse. Institutional desks tend to be more selective than social media traders screaming “buy the dip” into a candle they don’t understand.

XRP was trading around $1.43, with a 24-hour range of $1.41 to $1.47, according to the market data referenced alongside the filing. The token remains one of crypto’s most polarizing assets. Supporters argue that XRP has a real payments use case, backed by Ripple’s ecosystem and CEO Brad Garlinghouse, who has spent years making the case for XRP as a financial rail rather than a speculative bauble. Critics counter that XRP remains too centralized, too marketing-heavy, and too often carried by narrative momentum instead of broad monetary adoption.

Both sides have ammunition. XRP has longevity, brand recognition, and now ETF access that makes it easier for institutions to buy. It also carries baggage: years of regulatory drama, a messy perception problem, and a value proposition that looks very different from Bitcoin’s hard-money thesis. That’s the uncomfortable truth some XRP zealots don’t want to hear: not every crypto asset needs to be “the future of money,” and not every Wall Street allocation is a spiritual endorsement.

What makes this filing important is not that Marex bought XRP ETF shares. Institutions buying listed crypto products is no longer shocking. What matters is the pace and breadth of the accumulation. Spot XRP ETFs lower the friction for traditional capital, and that matters a lot when the buyer is a firm that needs compliance-friendly wrappers, clean execution, and a paper trail that won’t trigger a five-alarm fire in the risk department.

Still, one quarter of buying does not prove deep conviction. 13F filings are backward-looking. By the time the public sees them, the trade may already be partly done, adjusted, or even fading. That’s why reading too much into a single filing is a classic rookie mistake. It’s useful information, not gospel.

The broader takeaway is measured but real: institutional interest in XRP is building, and the ETF structure is making that interest easier to express. That is a legit milestone for XRP market legitimacy, even if it doesn’t magically cure the asset of its structural questions or turn it into the next Bitcoin. The market can be pragmatic like that — occasionally even when it’s being a little ridiculous.

For Bitcoiners, there’s a useful contrast here. Bitcoin remains the cleanest monetary asset in the space, with a simple story that doesn’t require a corporate ecosystem to justify its existence. XRP serves a different niche, and maybe that’s fine. Not every protocol needs to be Bitcoin. Some are payment rails, some are settlement experiments, some are speculative vehicles dressed up in a necktie.

What did Marex Group buy?

Marex bought a combined $9.4 million in spot XRP ETFs, split between the Canary XRP ETF and the Bitwise XRP ETF.

Why does a 13F filing matter for XRP investors?

A 13F filing shows what major institutions are holding. For XRP, it offers a rare look at whether traditional finance is actually accumulating ETF exposure or just talking a good game.

Does Marex’s position prove long-term institutional conviction in XRP?

No. It shows growing interest, but one quarter of buying does not confirm durable conviction or a long-term trend.

Who holds more XRP ETF exposure than Marex?

Goldman Sachs and Millennium Management were both cited as larger institutional holders of XRP ETF exposure.

Did Marex only buy XRP-related assets?

No. Marex also increased exposure to Strategy (MSTR) and STRK, while trimming some other digital asset positions.

What does this mean for XRP ETF adoption?

It suggests that XRP ETF products are gaining traction with institutional allocators, which could support broader legitimacy and liquidity over time.

What is the downside here?

ETF inflows can be fickle, and institutional buying often follows momentum rather than conviction. XRP also still carries centralization concerns, regulatory baggage, and a reputation that won’t disappear because a few firms bought the wrapper.

“Marex Group’s own stock climbed more than 15% in a week after the Nasdaq-listed financial services firm disclosed a combined $9.4 million position across two spot XRP exchange-traded funds…”

“That position grew 51% from the previous quarter…”

“The combined holdings pushed the firm among leading institutional ETF holders.”

“The firms ahead of Marex are not small players.”

“Marex sits well behind both, but its aggressive buying in a single quarter set it apart from many of its peers.”

“Sustained buying hasn’t been confirmed yet, though Q1 disclosures appear to signal growing confidence.”